Skip to content

TB transmission in healthcare settings and improving infection control

10% of new TB cases involve drug resistance

Most HIV-positive patients do as well as HIV-negative counterparts following surgery

CD4 cell loss in gut is not restored by HIV treatment, may have long-term consequences

GSK halts development of new PI, brecanavir

Atazanavir: genetic predictors for hyperbilirubinemia found

Is HIV causing cardiovascular disease by its own effects on cholesterol?

Triple nuke combination of AZT/3TC/tenofovir below current standards as a first-line regimen

Prezista (darunavir) approved for treatment-experienced patients in Europe